ClearPoint Neuro, Inc. CLPT
Rating
Rating Factors
Company Overview
ClearPoint Neuro, Inc. is a medical technology company operating in the neurosurgery and neuromodulation industries, with a focus on providing precision navigation and delivery solutions for minimally invasive brain procedures. The company develops and commercializes integrated platforms that enable neurosurgeons and interventional neurologists to accurately target and access structures within the brain under real-time imaging guidance.
The company’s primary revenue drivers are capital equipment sales, disposable surgical components, and service and licensing revenue associated with its navigation and delivery platforms. ClearPoint Neuro primarily serves hospitals, academic medical centers, and research institutions involved in functional neurosurgery, neuro-oncology, gene therapy, and drug delivery to the brain. Its strategic advantage lies in MRI-guided accuracy and compatibility with multiple therapeutic modalities. ClearPoint Neuro was founded in 1998 and has evolved from an early-stage navigation technology developer into a platform provider supporting both clinical care and investigational therapies.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $8.27
- Current
- $14.97
- High
- $30.10
Valuation
Dividends and Shares
Corporate Info
Suite 100
Solana Beach, CA 92075